Carrier and AWS Collaborate to Transform How Food, Medicine, Vaccines, and Other Perishable Goods Are Moved and Monitored Globally

SEATTLE & PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Today, Amazon Web Services, Inc. (AWS), an Amazon.com company (NASDAQ: AMZN), and Carrier Global Corporation (NYSE: CARR), a leading global provider of healthy, safe, and sustainable building and cold chain solutions, announced a multi-year agreement to co-develop Carrier’s new Lynx digital platform. This suite of tools will provide Carrier customers around the world with enhanced visibility, increased connectivity, and actionable intelligence across their cold chain operations to improve outcomes for temperature-sensitive cargo, including food, medicine, and vaccines. The collaboration builds on Carrier’s selection of AWS as its preferred cloud services provider in February 2020.

The Lynx platform will combine AWS’s IoT, analytics, and machine learning services with Carrier’s refrigeration and monitoring solutions, extending Carrier’s current digital offerings for managing the temperature-controlled transport and storage of perishables. Customers using the Lynx platform will benefit from end-to-end tracking, real-time alerts, automated processes, and

Read More

Nearly 1M deaths globally; New York City schools; flu

CLOSE

Approving a vaccine in the U.S. usually takes years, but COVID-19 vaccines are moving through in record time. What does that mean?

USA TODAY

With the global death toll from COVID-19 nearing 1 million, mass vaccinations remain unlikely until mid-2021, according to health experts.

An ideal vaccination would protect about 70% of those who are vaccinated, but the current minimum standard is 50%. Children may be last in line to receive a vaccine as none of the ongoing clinical trials include kids. While some health experts say it’s not a problem, others argue that it is because children can infect adults.

“We owe it to our children not to delay moving forward with initial studies to evaluate promising vaccine candidates,” Emory University School of Medicine pediatric infectious disease specialist Dr. Evan Anderson said last week.

Some significant developments:

  • South Korea health officials reported the country’s lowest daily increase of
Read More

Hydroxychloroquine Market to Garner $4.6 Billion, Globally, By 2027 at 7.9 % CAGR, Says Allied Market Research

– Increase in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria drive the growth of the global hydroxychloroquine market.

PORTLAND, Ore., Sept. 28, 2020 /PRNewswire/ — Allied Market Research published a report, titled, “Hydroxychloroquine Market by Product Type (Tablet and Active Pharmaceutical Ingredients), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Specialty Drug Store, and Retail Pharmacy), and Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027.” According to the report, the global hydroxychloroquine industry generated $1.9 billion in 2019, and is expected to generate $4.6 billion by 2027, witnessing a CAGR of 7.9% from 2020 to 2027. 

Allied_Market_Research_Logo
Allied_Market_Research_Logo

Prime determinants of growth

Increase in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria drive the growth of the global hydroxychloroquine market. However, ban in

Read More